
In Europe, the majority of stroke survivors leave hospital with a rehabilitation plan they will not be able to follow. The shortfalls are not clinical, guidelines are clear and therapists are trained. The problem is to be found in infrastructures incapable of delivering continuous, adaptive therapy outside a ward at scale.
Nyra Health (Austria, founded 2021) addresses the gap between inpatient discharge and long-term community care. The Vienna-based company built myReha, a patient-facing therapy platform for stroke, dementia, and acquired brain injury that operates across clinic and home settings without requiring specialist hardware. Its multimodal AI models process speech patterns, reaction times, error profiles, and training dynamics in real time, adjusting exercise content based on performance level, fatigue, and progress.
Therapists and care coordinators access a parallel layer, nyra insights, which delivers live patient performance dashboards and auto-generates session documentation. A Content Studio module allows clinics to personalise and deploy exercise libraries without engineering support.
The platform is embedded across 100+ rehabilitation clinics in the DACH region, with 28 statutory health funds reimbursing myReha under Germany's DiGA digital therapeutics framework. The company raised €20 million in a Series A round in February 2026, led by Armira Growth, with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma.
Sources: Nyra Health, Pulse 2.0, SAFE Europe